Director Paul Calvo will be moderating the panel, “An Update on the Current Legal Landscape for Biosimilars in the US,” at the Biosimilars Commercialisation Summit on May 15, 2019.

Panel Description:
  • Deep-dive into the latest updates on biosimilars litigation
  • Explore antitrust and unfair competition issues in biosimilar markets
  • Discuss the effects of anti-substitution legislation at the state level on biosimilar uptake